

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * synapsis (GO:0007129) | 9.47243509 |
| 2 | * chromosome organization involved in meiosis (GO:0070192) | 7.76353105 |
| 3 | DNA synthesis involved in DNA repair (GO:0000731) | 7.50853327 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.30817233 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.30817233 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.98721260 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.98721260 |
| 8 | nuclear pore complex assembly (GO:0051292) | 6.94989879 |
| 9 | synaptonemal complex assembly (GO:0007130) | 6.83553249 |
| 10 | piRNA metabolic process (GO:0034587) | 6.75886615 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 6.70616691 |
| 12 | DNA methylation involved in gamete generation (GO:0043046) | 6.52773434 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.39131567 |
| 14 | tryptophan catabolic process (GO:0006569) | 6.20457386 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 6.20457386 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 6.20457386 |
| 17 | synaptonemal complex organization (GO:0070193) | 6.10347664 |
| 18 | kynurenine metabolic process (GO:0070189) | 6.07531915 |
| 19 | nuclear pore organization (GO:0006999) | 6.06328371 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.97056214 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.80623154 |
| 22 | meiotic chromosome segregation (GO:0045132) | 5.75869731 |
| 23 | * male meiosis I (GO:0007141) | 5.73974658 |
| 24 | glyoxylate metabolic process (GO:0046487) | 5.69741974 |
| 25 | urea metabolic process (GO:0019627) | 5.64157381 |
| 26 | urea cycle (GO:0000050) | 5.64157381 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 5.62916052 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 5.61861119 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.61825794 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.57050298 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 5.55524829 |
| 32 | protein carboxylation (GO:0018214) | 5.53833530 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.53833530 |
| 34 | * male meiosis (GO:0007140) | 5.52553139 |
| 35 | regulation of fibrinolysis (GO:0051917) | 5.45962502 |
| 36 | cysteine metabolic process (GO:0006534) | 5.28839849 |
| 37 | pore complex assembly (GO:0046931) | 5.23895754 |
| 38 | regulation of complement activation (GO:0030449) | 5.21220146 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 5.17530309 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 5.11811642 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.09951692 |
| 42 | * meiotic nuclear division (GO:0007126) | 5.09287390 |
| 43 | bile acid metabolic process (GO:0008206) | 5.09118796 |
| 44 | regulation of meiosis I (GO:0060631) | 5.07958218 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 5.06771646 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.95138265 |
| 47 | * meiotic cell cycle process (GO:1903046) | 4.87648295 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.86515569 |
| 49 | reverse cholesterol transport (GO:0043691) | 4.84802901 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.81283928 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.81283928 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81283928 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 4.80342820 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.77819379 |
| 55 | * meiosis I (GO:0007127) | 4.76767193 |
| 56 | phospholipid efflux (GO:0033700) | 4.75870048 |
| 57 | sister chromatid cohesion (GO:0007062) | 4.75489249 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.69871845 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.69871845 |
| 60 | lysine metabolic process (GO:0006553) | 4.69786663 |
| 61 | lysine catabolic process (GO:0006554) | 4.69786663 |
| 62 | DNA replication checkpoint (GO:0000076) | 4.69344302 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 4.68975558 |
| 64 | triglyceride homeostasis (GO:0070328) | 4.66774470 |
| 65 | acylglycerol homeostasis (GO:0055090) | 4.66774470 |
| 66 | mitotic chromosome condensation (GO:0007076) | 4.59433944 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 4.57593149 |
| 68 | tyrosine metabolic process (GO:0006570) | 4.56946510 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 4.45058742 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.44641546 |
| 71 | mitotic sister chromatid cohesion (GO:0007064) | 4.43345251 |
| 72 | reciprocal meiotic recombination (GO:0007131) | 4.39527611 |
| 73 | reciprocal DNA recombination (GO:0035825) | 4.39527611 |
| 74 | regulation of translational fidelity (GO:0006450) | 4.39311226 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 4.38063920 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 4.33676635 |
| 77 | coenzyme catabolic process (GO:0009109) | 4.32242836 |
| 78 | glycine metabolic process (GO:0006544) | 4.30583182 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 4.29228699 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 4.27347054 |
| 81 | amine catabolic process (GO:0009310) | 4.27347054 |
| 82 | mitotic sister chromatid segregation (GO:0000070) | 4.26747353 |
| 83 | cholesterol efflux (GO:0033344) | 4.24623992 |
| 84 | DNA unwinding involved in DNA replication (GO:0006268) | 4.23780669 |
| 85 | sister chromatid segregation (GO:0000819) | 4.22551098 |
| 86 | mitotic nuclear envelope disassembly (GO:0007077) | 4.19193096 |
| 87 | cellular amino acid catabolic process (GO:0009063) | 4.19116865 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 4.17797260 |
| 89 | DNA replication initiation (GO:0006270) | 4.17328528 |
| 90 | cellular glucuronidation (GO:0052695) | 4.16353891 |
| 91 | fibrinolysis (GO:0042730) | 4.15715319 |
| 92 | serine family amino acid metabolic process (GO:0009069) | 4.10989555 |
| 93 | ethanol oxidation (GO:0006069) | 4.07689062 |
| 94 | glutamate metabolic process (GO:0006536) | 4.07550179 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 4.06100904 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01453307 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.95515164 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.94728449 |
| 99 | nuclear envelope disassembly (GO:0051081) | 3.93742833 |
| 100 | membrane disassembly (GO:0030397) | 3.93742833 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.91595702 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.90621910 |
| 103 | arginine metabolic process (GO:0006525) | 3.90438102 |
| 104 | gene silencing by RNA (GO:0031047) | 3.90208946 |
| 105 | complement activation (GO:0006956) | 3.88870677 |
| 106 | diterpenoid biosynthetic process (GO:0016102) | 3.87514726 |
| 107 | drug catabolic process (GO:0042737) | 3.85930503 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 3.85921526 |
| 109 | DNA topological change (GO:0006265) | 3.85504078 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84924304 |
| 111 | protein activation cascade (GO:0072376) | 3.83832554 |
| 112 | regulation of DNA endoreduplication (GO:0032875) | 3.83645681 |
| 113 | acute-phase response (GO:0006953) | 3.80810387 |
| 114 | positive regulation of lipid catabolic process (GO:0050996) | 3.79325629 |
| 115 | opsonization (GO:0008228) | 3.78923662 |
| 116 | cellular modified amino acid catabolic process (GO:0042219) | 3.78113437 |
| 117 | aldehyde catabolic process (GO:0046185) | 3.77249160 |
| 118 | cofactor catabolic process (GO:0051187) | 3.76916450 |
| 119 | * resolution of meiotic recombination intermediates (GO:0000712) | 3.74312470 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73707607 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73707607 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 3.72227041 |
| 123 | cytolysis (GO:0019835) | 3.71433310 |
| 124 | microtubule depolymerization (GO:0007019) | 3.70762479 |
| 125 | carboxylic acid catabolic process (GO:0046395) | 3.70364866 |
| 126 | organic acid catabolic process (GO:0016054) | 3.70364866 |
| 127 | ketone body metabolic process (GO:1902224) | 3.69637137 |
| 128 | cholesterol homeostasis (GO:0042632) | 3.68787465 |
| 129 | glucuronate metabolic process (GO:0019585) | 3.66805644 |
| 130 | uronic acid metabolic process (GO:0006063) | 3.66805644 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 3.63919958 |
| 132 | sterol homeostasis (GO:0055092) | 3.62406815 |
| 133 | DNA packaging (GO:0006323) | 3.62130186 |
| 134 | NAD biosynthetic process (GO:0009435) | 3.62067099 |
| 135 | heme transport (GO:0015886) | 3.61951956 |
| 136 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.61320530 |
| 137 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.61320530 |
| 138 | protein-lipid complex assembly (GO:0065005) | 3.60257373 |
| 139 | formation of translation preinitiation complex (GO:0001731) | 3.59328054 |
| 140 | kinetochore organization (GO:0051383) | 3.54683888 |
| 141 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.53302291 |
| 142 | mitotic metaphase plate congression (GO:0007080) | 3.52558216 |
| 143 | chromosome segregation (GO:0007059) | 3.51935229 |
| 144 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.48947738 |
| 145 | histone exchange (GO:0043486) | 3.48760669 |
| 146 | mitotic spindle assembly checkpoint (GO:0007094) | 3.46163490 |
| 147 | DNA strand elongation (GO:0022616) | 3.44162477 |
| 148 | mitotic spindle checkpoint (GO:0071174) | 3.43924325 |
| 149 | regulation of histone H3-K4 methylation (GO:0051569) | 3.38609263 |
| 150 | spindle assembly checkpoint (GO:0071173) | 3.38404343 |
| 151 | histone H2A acetylation (GO:0043968) | 3.34303410 |
| 152 | negative regulation of chromosome segregation (GO:0051985) | 3.33677152 |
| 153 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.33609949 |
| 154 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.33609949 |
| 155 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.33609949 |
| 156 | negative regulation of sister chromatid segregation (GO:0033046) | 3.33609949 |
| 157 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.33609949 |
| 158 | regulation of histone H3-K9 methylation (GO:0051570) | 3.32511145 |
| 159 | metaphase plate congression (GO:0051310) | 3.32419847 |
| 160 | protein localization to chromosome (GO:0034502) | 3.32157959 |
| 161 | * chromosome organization (GO:0051276) | 3.31799331 |
| 162 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30938215 |
| 163 | regulation of RNA export from nucleus (GO:0046831) | 3.30137942 |
| 164 | CENP-A containing nucleosome assembly (GO:0034080) | 3.28616381 |
| 165 | regulation of chromosome segregation (GO:0051983) | 3.27363915 |
| 166 | regulation of centriole replication (GO:0046599) | 3.19475988 |
| 167 | chromosome condensation (GO:0030261) | 3.18954812 |
| 168 | IMP biosynthetic process (GO:0006188) | 3.17906988 |
| 169 | spindle checkpoint (GO:0031577) | 3.14948025 |
| 170 | chromatin remodeling at centromere (GO:0031055) | 3.13777731 |
| 171 | proteasome assembly (GO:0043248) | 3.11715396 |
| 172 | purine nucleobase biosynthetic process (GO:0009113) | 3.11524790 |
| 173 | mismatch repair (GO:0006298) | 3.11055428 |
| 174 | protein localization to kinetochore (GO:0034501) | 3.09476503 |
| 175 | regulation of centrosome cycle (GO:0046605) | 3.09230123 |
| 176 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.04971863 |
| 177 | histone H3-K9 demethylation (GO:0033169) | 3.03767543 |
| 178 | regulation of mitotic spindle organization (GO:0060236) | 3.02460607 |
| 179 | DNA replication-independent nucleosome organization (GO:0034724) | 3.02312104 |
| 180 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.02312104 |
| 181 | regulation of histone H3-K27 methylation (GO:0061085) | 3.02206982 |
| 182 | DNA methylation (GO:0006306) | 3.01519880 |
| 183 | DNA alkylation (GO:0006305) | 3.01519880 |
| 184 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.00363587 |
| 185 | terpenoid biosynthetic process (GO:0016114) | 3.00311508 |
| 186 | regulation of sister chromatid segregation (GO:0033045) | 2.99255763 |
| 187 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.99255763 |
| 188 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.99255763 |
| 189 | DNA conformation change (GO:0071103) | 2.97365985 |
| 190 | regulation of histone methylation (GO:0031060) | 2.97120349 |
| 191 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.96033435 |
| 192 | mitotic recombination (GO:0006312) | 2.95218824 |
| 193 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.92504434 |
| 194 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.92504434 |
| 195 | protein localization to chromosome, centromeric region (GO:0071459) | 2.91630450 |
| 196 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.90525355 |
| 197 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.90525355 |
| 198 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.90264876 |
| 199 | vitamin A metabolic process (GO:0006776) | 2.89414163 |
| 200 | DNA biosynthetic process (GO:0071897) | 2.87831255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.26032672 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.22753381 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.29064508 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.10772900 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41203309 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14162413 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03165620 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89643459 |
| 9 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 4.62846354 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.35433849 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.21673589 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.94698035 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.92480307 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.58107385 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.33170532 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.33017391 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.72661574 |
| 18 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.65260494 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60298233 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.52558388 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.50759445 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.45592508 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.44658414 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.44592227 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.40667805 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.37370624 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.35956148 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.30664895 |
| 29 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.29361091 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.29235981 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28419717 |
| 32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28232237 |
| 33 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.24724305 |
| 34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.22425202 |
| 35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.10639984 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.10085778 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.03713028 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7989474 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99192176 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98901351 |
| 41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.98005173 |
| 42 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95229270 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.94836347 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93235673 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.87027887 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86262600 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86062824 |
| 48 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.84556042 |
| 49 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.84321901 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83837924 |
| 51 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80797660 |
| 52 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.80400172 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.75555807 |
| 54 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.74462721 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.70287807 |
| 56 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.67686339 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63893039 |
| 58 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62459636 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59979911 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58789648 |
| 61 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.57174653 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53219488 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52114779 |
| 64 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.51109762 |
| 65 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.47279454 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46110638 |
| 67 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37545276 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.32876467 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31173574 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29574467 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29201648 |
| 72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.28808869 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27835689 |
| 74 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19072686 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17841793 |
| 76 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17804942 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14050600 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13387794 |
| 79 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12398885 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11634827 |
| 81 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10188750 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09123619 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08789309 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08470219 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08002528 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07597759 |
| 87 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06871088 |
| 88 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05952800 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03839368 |
| 90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03547338 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02961559 |
| 92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00869888 |
| 93 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98825312 |
| 94 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98172797 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97290597 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96050987 |
| 97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95696551 |
| 98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93650435 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93129868 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92799350 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92653784 |
| 102 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92130266 |
| 103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91571153 |
| 104 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89900649 |
| 105 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.88883621 |
| 106 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.88883621 |
| 107 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.88883621 |
| 108 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.88007414 |
| 109 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87474578 |
| 110 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86562879 |
| 111 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.86543712 |
| 112 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.85161483 |
| 113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84714153 |
| 114 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84222400 |
| 115 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83490600 |
| 116 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83400177 |
| 117 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.82786385 |
| 118 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82420792 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82180340 |
| 120 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.82132706 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82114140 |
| 122 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.81630109 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81435177 |
| 124 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81218951 |
| 125 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.81101421 |
| 126 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80444164 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79419028 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78978239 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78061132 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75676204 |
| 131 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75219760 |
| 132 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73036217 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72513987 |
| 134 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71892778 |
| 135 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68633907 |
| 136 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67968603 |
| 137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.67877834 |
| 138 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.67621534 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.65346302 |
| 140 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64896918 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64544489 |
| 142 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63779809 |
| 143 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.63127457 |
| 144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62160255 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61421141 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61398628 |
| 147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60917191 |
| 148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.59950056 |
| 149 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.58506355 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58268432 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57975145 |
| 152 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.55546620 |
| 153 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.54482208 |
| 154 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.54195102 |
| 155 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54064300 |
| 156 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53881781 |
| 157 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53881781 |
| 158 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52397115 |
| 159 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52348365 |
| 160 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52134259 |
| 161 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.51532427 |
| 162 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.51388025 |
| 163 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50850545 |
| 164 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.50348339 |
| 165 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.50159896 |
| 166 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49507660 |
| 167 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.48721154 |
| 168 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.48317755 |
| 169 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.47632485 |
| 170 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47566772 |
| 171 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.46875808 |
| 172 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.46599368 |
| 173 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45846686 |
| 174 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.45123467 |
| 175 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.45103010 |
| 176 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.44720973 |
| 177 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.44472348 |
| 178 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44309031 |
| 179 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.44050540 |
| 180 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.43708821 |
| 181 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42302334 |
| 182 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.41977487 |
| 183 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.41171705 |
| 184 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.41119790 |
| 185 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40787262 |
| 186 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.40707650 |
| 187 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.40643520 |
| 188 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.39986912 |
| 189 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39942164 |
| 190 | NCOR_22424771_ChIP-Seq_293T_Human | 0.39039372 |
| 191 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38360294 |
| 192 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.38182382 |
| 193 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37555355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.51497856 |
| 2 | MP0005360_urolithiasis | 7.50255914 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.39976866 |
| 4 | MP0005365_abnormal_bile_salt | 6.25452118 |
| 5 | MP0008058_abnormal_DNA_repair | 4.88663184 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87662152 |
| 7 | MP0008877_abnormal_DNA_methylation | 4.52215032 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 4.24558171 |
| 9 | MP0004147_increased_porphyrin_level | 4.18425338 |
| 10 | MP0003252_abnormal_bile_duct | 3.96988634 |
| 11 | MP0010094_abnormal_chromosome_stability | 3.80313445 |
| 12 | MP0003111_abnormal_nucleus_morphology | 3.66803918 |
| 13 | MP0010329_abnormal_lipoprotein_level | 3.57563678 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 3.57021647 |
| 15 | MP0008995_early_reproductive_senescence | 3.35433465 |
| 16 | MP0002210_abnormal_sex_determination | 3.32603813 |
| 17 | MP0008057_abnormal_DNA_replication | 3.29316900 |
| 18 | MP0003693_abnormal_embryo_hatching | 3.21046303 |
| 19 | MP0001929_abnormal_gametogenesis | 3.03877421 |
| 20 | MP0003195_calcinosis | 3.02884657 |
| 21 | MP0009840_abnormal_foam_cell | 3.00073984 |
| 22 | MP0005083_abnormal_biliary_tract | 2.87302524 |
| 23 | MP0000678_abnormal_parathyroid_gland | 2.70893819 |
| 24 | MP0005332_abnormal_amino_acid | 2.69216422 |
| 25 | MP0008007_abnormal_cellular_replicative | 2.51257139 |
| 26 | MP0003077_abnormal_cell_cycle | 2.49982484 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.49357187 |
| 28 | MP0001145_abnormal_male_reproductive | 2.49289283 |
| 29 | MP0008932_abnormal_embryonic_tissue | 2.45938102 |
| 30 | MP0003698_abnormal_male_reproductive | 2.35153933 |
| 31 | MP0003786_premature_aging | 2.34742040 |
| 32 | MP0000653_abnormal_sex_gland | 2.32973956 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 2.24135308 |
| 34 | MP0000609_abnormal_liver_physiology | 2.14464886 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 2.09756472 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 2.03723871 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.91644802 |
| 38 | MP0001730_embryonic_growth_arrest | 1.78605790 |
| 39 | MP0002160_abnormal_reproductive_system | 1.78576437 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.76320288 |
| 41 | MP0003868_abnormal_feces_composition | 1.76125733 |
| 42 | MP0010307_abnormal_tumor_latency | 1.75833298 |
| 43 | MP0009697_abnormal_copulation | 1.66518621 |
| 44 | MP0001764_abnormal_homeostasis | 1.60441904 |
| 45 | MP0001697_abnormal_embryo_size | 1.54387347 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.50974903 |
| 47 | MP0001119_abnormal_female_reproductive | 1.48037087 |
| 48 | MP0002161_abnormal_fertility/fecundity | 1.47720515 |
| 49 | MP0003646_muscle_fatigue | 1.44533512 |
| 50 | MP0001672_abnormal_embryogenesis/_devel | 1.40209448 |
| 51 | MP0005380_embryogenesis_phenotype | 1.40209448 |
| 52 | MP0000350_abnormal_cell_proliferation | 1.39142433 |
| 53 | MP0003011_delayed_dark_adaptation | 1.38805032 |
| 54 | MP0002254_reproductive_system_inflammat | 1.38743635 |
| 55 | MP0005647_abnormal_sex_gland | 1.34192900 |
| 56 | MP0005451_abnormal_body_composition | 1.32819432 |
| 57 | MP0002080_prenatal_lethality | 1.31620289 |
| 58 | MP0002132_abnormal_respiratory_system | 1.24459355 |
| 59 | MP0000313_abnormal_cell_death | 1.23205226 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.22087641 |
| 61 | MP0003890_abnormal_embryonic-extraembry | 1.20455335 |
| 62 | MP0009764_decreased_sensitivity_to | 1.19412480 |
| 63 | MP0000358_abnormal_cell_content/ | 1.19183352 |
| 64 | MP0003984_embryonic_growth_retardation | 1.19016382 |
| 65 | MP0002084_abnormal_developmental_patter | 1.18404800 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.18339522 |
| 67 | MP0003186_abnormal_redox_activity | 1.17509964 |
| 68 | MP0002088_abnormal_embryonic_growth/wei | 1.15575930 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.14010300 |
| 70 | MP0000598_abnormal_liver_morphology | 1.12982769 |
| 71 | MP0005389_reproductive_system_phenotype | 1.11981847 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.09674769 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.09674769 |
| 74 | MP0002085_abnormal_embryonic_tissue | 1.09376697 |
| 75 | MP0003567_abnormal_fetal_cardiomyocyte | 1.09309119 |
| 76 | MP0006292_abnormal_olfactory_placode | 1.07452774 |
| 77 | MP0009763_increased_sensitivity_to | 1.06362473 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.00876638 |
| 79 | MP0004233_abnormal_muscle_weight | 0.99579589 |
| 80 | MP0005670_abnormal_white_adipose | 0.98819829 |
| 81 | MP0010368_abnormal_lymphatic_system | 0.98255012 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 0.97735946 |
| 83 | MP0000604_amyloidosis | 0.97393124 |
| 84 | MP0008469_abnormal_protein_level | 0.95798504 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.92981461 |
| 86 | MP0003937_abnormal_limbs/digits/tail_de | 0.92592033 |
| 87 | MP0000647_abnormal_sebaceous_gland | 0.90567900 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.88561023 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.88095892 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.86322475 |
| 91 | MP0004197_abnormal_fetal_growth/weight/ | 0.84287467 |
| 92 | MP0002269_muscular_atrophy | 0.83461146 |
| 93 | MP0002971_abnormal_brown_adipose | 0.83115596 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.82607779 |
| 95 | MP0003959_abnormal_lean_body | 0.81865131 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.81645041 |
| 97 | MP0006082_CNS_inflammation | 0.81612284 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.81582614 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.81509962 |
| 100 | MP0009703_decreased_birth_body | 0.81373291 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.81193706 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.78336902 |
| 103 | MP0003123_paternal_imprinting | 0.78218950 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.76608276 |
| 105 | MP0003385_abnormal_body_wall | 0.76567464 |
| 106 | MP0003690_abnormal_glial_cell | 0.76516099 |
| 107 | MP0005535_abnormal_body_temperature | 0.74949851 |
| 108 | MP0004130_abnormal_muscle_cell | 0.72933323 |
| 109 | MP0005334_abnormal_fat_pad | 0.71914204 |
| 110 | MP0005410_abnormal_fertilization | 0.71687598 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.70447364 |
| 112 | MP0005266_abnormal_metabolism | 0.70340332 |
| 113 | MP0001661_extended_life_span | 0.68593856 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.66576115 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.66431488 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.65310957 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.65249053 |
| 118 | MP0005408_hypopigmentation | 0.64707858 |
| 119 | MP0001529_abnormal_vocalization | 0.64362541 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.63655126 |
| 121 | MP0003724_increased_susceptibility_to | 0.63648637 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 0.62641490 |
| 123 | MP0003936_abnormal_reproductive_system | 0.62537436 |
| 124 | MP0002938_white_spotting | 0.61830415 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.60689291 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.60493792 |
| 127 | MP0006072_abnormal_retinal_apoptosis | 0.59882506 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.58412523 |
| 129 | MP0003943_abnormal_hepatobiliary_system | 0.57571073 |
| 130 | MP0000266_abnormal_heart_morphology | 0.56924875 |
| 131 | MP0005174_abnormal_tail_pigmentation | 0.56814310 |
| 132 | MP0005395_other_phenotype | 0.55280315 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54684901 |
| 134 | MP0003935_abnormal_craniofacial_develop | 0.54325445 |
| 135 | MP0005448_abnormal_energy_balance | 0.52929597 |
| 136 | MP0005384_cellular_phenotype | 0.52634693 |
| 137 | MP0000703_abnormal_thymus_morphology | 0.52155036 |
| 138 | MP0001756_abnormal_urination | 0.51515470 |
| 139 | MP0003718_maternal_effect | 0.51475933 |
| 140 | MP0009053_abnormal_anal_canal | 0.51144389 |
| 141 | MP0008770_decreased_survivor_rate | 0.49784134 |
| 142 | MP0005645_abnormal_hypothalamus_physiol | 0.49751198 |
| 143 | MP0004043_abnormal_pH_regulation | 0.48759579 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.48673263 |
| 145 | MP0002136_abnormal_kidney_physiology | 0.47361870 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.47128927 |
| 147 | MP0009672_abnormal_birth_weight | 0.46953800 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.46840482 |
| 149 | MP0000681_abnormal_thyroid_gland | 0.46579382 |
| 150 | MP0003329_amyloid_beta_deposits | 0.45923618 |
| 151 | MP0003436_decreased_susceptibility_to | 0.45218425 |
| 152 | MP0008874_decreased_physiological_sensi | 0.44240770 |
| 153 | MP0002060_abnormal_skin_morphology | 0.42229553 |
| 154 | MP0005166_decreased_susceptibility_to | 0.40645618 |
| 155 | MP0002928_abnormal_bile_duct | 0.40470026 |
| 156 | MP0003953_abnormal_hormone_level | 0.40454830 |
| 157 | MP0000579_abnormal_nail_morphology | 0.39829740 |
| 158 | MP0002822_catalepsy | 0.38740139 |
| 159 | MP0002168_other_aberrant_phenotype | 0.37945848 |
| 160 | MP0008873_increased_physiological_sensi | 0.37560104 |
| 161 | MP0009115_abnormal_fat_cell | 0.37430433 |
| 162 | MP0003075_altered_response_to | 0.36686200 |
| 163 | MP0002970_abnormal_white_adipose | 0.35341435 |
| 164 | MP0001853_heart_inflammation | 0.35224266 |
| 165 | MP0004782_abnormal_surfactant_physiolog | 0.35015699 |
| 166 | MP0004381_abnormal_hair_follicle | 0.34382876 |
| 167 | MP0005248_abnormal_Harderian_gland | 0.34328030 |
| 168 | MP0001243_abnormal_dermal_layer | 0.34234662 |
| 169 | MP0008872_abnormal_physiological_respon | 0.33061390 |
| 170 | MP0002796_impaired_skin_barrier | 0.32738577 |
| 171 | MP0000249_abnormal_blood_vessel | 0.31672083 |
| 172 | MP0001845_abnormal_inflammatory_respons | 0.31081481 |
| 173 | MP0000427_abnormal_hair_cycle | 0.29050969 |
| 174 | MP0009785_altered_susceptibility_to | 0.28344724 |
| 175 | MP0000230_abnormal_systemic_arterial | 0.28129260 |
| 176 | MP0004883_abnormal_blood_vessel | 0.27106464 |
| 177 | MP0005164_abnormal_response_to | 0.27053757 |
| 178 | MP0002837_dystrophic_cardiac_calcinosis | 0.26927825 |
| 179 | MP0005595_abnormal_vascular_smooth | 0.26761018 |
| 180 | MP0003699_abnormal_female_reproductive | 0.25714873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.43157142 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.33498722 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.12459724 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.79215429 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.59636902 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51301928 |
| 7 | Xanthomatosis (HP:0000991) | 6.18000619 |
| 8 | Complement deficiency (HP:0004431) | 5.63752727 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.44991490 |
| 10 | Joint hemorrhage (HP:0005261) | 5.01107052 |
| 11 | Truncus arteriosus (HP:0001660) | 4.90051506 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.87363234 |
| 13 | Chromsome breakage (HP:0040012) | 4.83917903 |
| 14 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.75493672 |
| 15 | Hyperammonemia (HP:0001987) | 4.51934522 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47354263 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.47214567 |
| 18 | Epidermoid cyst (HP:0200040) | 4.41285025 |
| 19 | Hyperglycinemia (HP:0002154) | 4.31674045 |
| 20 | Fat malabsorption (HP:0002630) | 4.21023183 |
| 21 | Reticulocytosis (HP:0001923) | 4.20545450 |
| 22 | Ketosis (HP:0001946) | 4.17179773 |
| 23 | Abnormality of complement system (HP:0005339) | 4.17104805 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.15367735 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06225000 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 4.04427757 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.03982213 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.94292656 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.92008672 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.90126321 |
| 31 | Hyperthyroidism (HP:0000836) | 3.86422283 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.83447896 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79499411 |
| 34 | Increased nuchal translucency (HP:0010880) | 3.76772687 |
| 35 | Hyperglycinuria (HP:0003108) | 3.76500154 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.74407214 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.74407214 |
| 38 | Abnormality of reticulocytes (HP:0004312) | 3.66905198 |
| 39 | Volvulus (HP:0002580) | 3.66239887 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.62776947 |
| 41 | Birth length less than 3rd percentile (HP:0003561) | 3.60838426 |
| 42 | Spontaneous abortion (HP:0005268) | 3.54729703 |
| 43 | Abnormality of cochlea (HP:0000375) | 3.44810728 |
| 44 | Bowel incontinence (HP:0002607) | 3.32520687 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31626185 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29486717 |
| 47 | Hyperbilirubinemia (HP:0002904) | 3.25252098 |
| 48 | Steatorrhea (HP:0002570) | 3.22103173 |
| 49 | Abnormal large intestine physiology (HP:0012700) | 3.18139902 |
| 50 | Small intestinal stenosis (HP:0012848) | 3.13445902 |
| 51 | Duodenal stenosis (HP:0100867) | 3.13445902 |
| 52 | Upper limb muscle weakness (HP:0003484) | 3.12991027 |
| 53 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.11864938 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 3.08519153 |
| 55 | Ankyloglossia (HP:0010296) | 3.08238419 |
| 56 | Myocardial infarction (HP:0001658) | 3.07816912 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 3.02733867 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.99955821 |
| 59 | Ketoacidosis (HP:0001993) | 2.95829992 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95066989 |
| 61 | Abnormal lung lobation (HP:0002101) | 2.94765163 |
| 62 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.93333339 |
| 63 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.93333339 |
| 64 | Polycythemia (HP:0001901) | 2.93014447 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.86431176 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.83131644 |
| 67 | Cortical dysplasia (HP:0002539) | 2.77927556 |
| 68 | Gonadotropin excess (HP:0000837) | 2.77828157 |
| 69 | Metabolic acidosis (HP:0001942) | 2.74593808 |
| 70 | Abnormal hemoglobin (HP:0011902) | 2.69292764 |
| 71 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.68954262 |
| 72 | Duplicated collecting system (HP:0000081) | 2.68902585 |
| 73 | Acanthocytosis (HP:0001927) | 2.68207141 |
| 74 | Vascular calcification (HP:0004934) | 2.65582141 |
| 75 | Skin nodule (HP:0200036) | 2.64669782 |
| 76 | Glomerulonephritis (HP:0000099) | 2.63940250 |
| 77 | Abnormality of glycolysis (HP:0004366) | 2.63858352 |
| 78 | Acute myeloid leukemia (HP:0004808) | 2.63054604 |
| 79 | Progressive external ophthalmoplegia (HP:0000590) | 2.62206225 |
| 80 | Hypoparathyroidism (HP:0000829) | 2.61600001 |
| 81 | Atelectasis (HP:0100750) | 2.58352449 |
| 82 | Increased serum pyruvate (HP:0003542) | 2.57755978 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.56637380 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56637380 |
| 85 | Lethargy (HP:0001254) | 2.55142352 |
| 86 | Reticulocytopenia (HP:0001896) | 2.53664666 |
| 87 | Myelodysplasia (HP:0002863) | 2.53607416 |
| 88 | Abnormality of purine metabolism (HP:0004352) | 2.52850777 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51449621 |
| 90 | Abnormality of the duodenum (HP:0002246) | 2.51410903 |
| 91 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.51246306 |
| 92 | Abnormality of the preputium (HP:0100587) | 2.50112307 |
| 93 | Abnormality of the renal collecting system (HP:0004742) | 2.49432711 |
| 94 | Ileus (HP:0002595) | 2.48792060 |
| 95 | Abnormality of chromosome stability (HP:0003220) | 2.47371412 |
| 96 | Morphological abnormality of the inner ear (HP:0011390) | 2.45177797 |
| 97 | Azoospermia (HP:0000027) | 2.44960034 |
| 98 | Hypoglycemic seizures (HP:0002173) | 2.44875769 |
| 99 | Cardiovascular calcification (HP:0011915) | 2.42829097 |
| 100 | Cerebral edema (HP:0002181) | 2.41632153 |
| 101 | Abnormality of DNA repair (HP:0003254) | 2.39153574 |
| 102 | Malnutrition (HP:0004395) | 2.37169730 |
| 103 | Ectopic kidney (HP:0000086) | 2.36684178 |
| 104 | Hypertensive crisis (HP:0100735) | 2.36667205 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 2.36236734 |
| 106 | Cholecystitis (HP:0001082) | 2.36236734 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 2.35667241 |
| 108 | Tubulointerstitial nephritis (HP:0001970) | 2.35417420 |
| 109 | Abnormality of homocysteine metabolism (HP:0010919) | 2.35389440 |
| 110 | Homocystinuria (HP:0002156) | 2.35389440 |
| 111 | Obsessive-compulsive behavior (HP:0000722) | 2.35074799 |
| 112 | Mitral stenosis (HP:0001718) | 2.32249341 |
| 113 | Cholelithiasis (HP:0001081) | 2.31753987 |
| 114 | Amyloidosis (HP:0011034) | 2.30645920 |
| 115 | Spastic diplegia (HP:0001264) | 2.30584571 |
| 116 | Hemorrhage of the eye (HP:0011885) | 2.29777572 |
| 117 | Abnormality of the tricuspid valve (HP:0001702) | 2.29538380 |
| 118 | Shoulder girdle muscle weakness (HP:0003547) | 2.29180195 |
| 119 | Rimmed vacuoles (HP:0003805) | 2.25762176 |
| 120 | Gingival bleeding (HP:0000225) | 2.25206179 |
| 121 | Seborrheic dermatitis (HP:0001051) | 2.24979291 |
| 122 | Neonatal onset (HP:0003623) | 2.23813189 |
| 123 | Pallor (HP:0000980) | 2.23303278 |
| 124 | Abnormality of the labia minora (HP:0012880) | 2.22420291 |
| 125 | Rhabdomyosarcoma (HP:0002859) | 2.21470410 |
| 126 | Irritability (HP:0000737) | 2.19995212 |
| 127 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.19171698 |
| 128 | Microvesicular hepatic steatosis (HP:0001414) | 2.18042701 |
| 129 | Embryonal renal neoplasm (HP:0011794) | 2.17054329 |
| 130 | Pancreatitis (HP:0001733) | 2.15221196 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 2.15040528 |
| 132 | Abnormality of the corticospinal tract (HP:0002492) | 2.14165045 |
| 133 | Thrombophlebitis (HP:0004418) | 2.13585054 |
| 134 | Renal cortical cysts (HP:0000803) | 2.13273287 |
| 135 | Brushfield spots (HP:0001088) | 2.12985136 |
| 136 | Late onset (HP:0003584) | 2.12730501 |
| 137 | Short middle phalanx of the 5th finger (HP:0004220) | 2.12592693 |
| 138 | Menorrhagia (HP:0000132) | 2.12159605 |
| 139 | Poikilocytosis (HP:0004447) | 2.11114236 |
| 140 | Redundant skin (HP:0001582) | 2.10879321 |
| 141 | Enlarged kidneys (HP:0000105) | 2.10519031 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10156309 |
| 143 | Premature ovarian failure (HP:0008209) | 2.09989396 |
| 144 | Upper motor neuron abnormality (HP:0002127) | 2.08390796 |
| 145 | Gout (HP:0001997) | 2.08207736 |
| 146 | Abnormality of chromosome segregation (HP:0002916) | 2.06467929 |
| 147 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04648092 |
| 148 | Meckel diverticulum (HP:0002245) | 2.04615579 |
| 149 | Sandal gap (HP:0001852) | 2.04372378 |
| 150 | Esophageal varix (HP:0002040) | 2.03956940 |
| 151 | Vomiting (HP:0002013) | 2.02073825 |
| 152 | Nephritis (HP:0000123) | 2.01299599 |
| 153 | Generalized aminoaciduria (HP:0002909) | 2.00798257 |
| 154 | Cafe-au-lait spot (HP:0000957) | 2.00242366 |
| 155 | Abnormality of oral frenula (HP:0000190) | 2.00082654 |
| 156 | 11 pairs of ribs (HP:0000878) | 1.98037330 |
| 157 | Sensorimotor neuropathy (HP:0007141) | 1.97671836 |
| 158 | Abnormality of the gallbladder (HP:0005264) | 1.95174285 |
| 159 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.93716513 |
| 160 | Overlapping toe (HP:0001845) | 1.91667134 |
| 161 | Metaphyseal cupping (HP:0003021) | 1.91605483 |
| 162 | Abnormality of the ileum (HP:0001549) | 1.90508621 |
| 163 | Elevated hepatic transaminases (HP:0002910) | 1.88955553 |
| 164 | Abnormal biliary tract physiology (HP:0012439) | 1.88123808 |
| 165 | Bile duct proliferation (HP:0001408) | 1.88123808 |
| 166 | Sloping forehead (HP:0000340) | 1.87923154 |
| 167 | Abnormal spermatogenesis (HP:0008669) | 1.87560513 |
| 168 | Abnormal cartilage morphology (HP:0002763) | 1.83910858 |
| 169 | Rickets (HP:0002748) | 1.83648241 |
| 170 | Nonimmune hydrops fetalis (HP:0001790) | 1.82537911 |
| 171 | Neoplasm of the colon (HP:0100273) | 1.81967354 |
| 172 | Oligodactyly (hands) (HP:0001180) | 1.81044119 |
| 173 | Opisthotonus (HP:0002179) | 1.80337201 |
| 174 | Osteomalacia (HP:0002749) | 1.79908132 |
| 175 | Attention deficit hyperactivity disorder (HP:0007018) | 1.79704927 |
| 176 | Neoplasm of the small intestine (HP:0100833) | 1.78466161 |
| 177 | Hypertriglyceridemia (HP:0002155) | 1.76100097 |
| 178 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75868774 |
| 179 | Nausea (HP:0002018) | 1.75008258 |
| 180 | Proximal tubulopathy (HP:0000114) | 1.74992575 |
| 181 | Hypophosphatemic rickets (HP:0004912) | 1.74802997 |
| 182 | Horseshoe kidney (HP:0000085) | 1.74305123 |
| 183 | Hydroxyprolinuria (HP:0003080) | 1.73764036 |
| 184 | Abnormality of the carotid arteries (HP:0005344) | 1.71753064 |
| 185 | Ependymoma (HP:0002888) | 1.68232327 |
| 186 | Secondary amenorrhea (HP:0000869) | 1.67939649 |
| 187 | Large hands (HP:0001176) | 1.67157116 |
| 188 | Scotoma (HP:0000575) | 1.66771515 |
| 189 | Neoplasm of the oral cavity (HP:0100649) | 1.64399856 |
| 190 | Choanal atresia (HP:0000453) | 1.63483934 |
| 191 | Breech presentation (HP:0001623) | 1.62060103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.11586515 |
| 2 | TTK | 4.55551796 |
| 3 | FGFR4 | 4.32774086 |
| 4 | SIK1 | 4.26096626 |
| 5 | ERN1 | 4.04544528 |
| 6 | PNCK | 3.36088061 |
| 7 | EIF2AK1 | 3.35257951 |
| 8 | KSR2 | 3.25087998 |
| 9 | PLK4 | 3.15510096 |
| 10 | TAOK3 | 3.09240757 |
| 11 | PDK4 | 3.05434080 |
| 12 | PDK3 | 3.05434080 |
| 13 | BUB1 | 2.89435866 |
| 14 | WEE1 | 2.86031870 |
| 15 | INSRR | 2.83121363 |
| 16 | MST1R | 2.80153024 |
| 17 | CLK1 | 2.72184274 |
| 18 | ERBB4 | 2.64229560 |
| 19 | NTRK3 | 2.50910533 |
| 20 | MAP3K2 | 2.48539932 |
| 21 | NEK1 | 2.25485251 |
| 22 | CDC7 | 2.22925328 |
| 23 | BRSK2 | 2.22387388 |
| 24 | RAF1 | 2.18718847 |
| 25 | RIPK4 | 2.10925089 |
| 26 | KSR1 | 2.09419915 |
| 27 | LATS1 | 2.07127427 |
| 28 | CCNB1 | 2.04033556 |
| 29 | PIK3CG | 1.97626613 |
| 30 | MAP2K4 | 1.93526982 |
| 31 | EIF2AK3 | 1.84275724 |
| 32 | PBK | 1.77567941 |
| 33 | MAP3K4 | 1.76007514 |
| 34 | PKN2 | 1.72465027 |
| 35 | TYK2 | 1.71885829 |
| 36 | BMPR2 | 1.69162416 |
| 37 | PDK2 | 1.64680092 |
| 38 | MAPK11 | 1.61880231 |
| 39 | TSSK6 | 1.61680873 |
| 40 | EEF2K | 1.58573600 |
| 41 | ZAK | 1.56199011 |
| 42 | SRPK1 | 1.55537120 |
| 43 | STK38L | 1.53283984 |
| 44 | FLT3 | 1.53007462 |
| 45 | PLK1 | 1.49750302 |
| 46 | NEK2 | 1.48820288 |
| 47 | TRIB3 | 1.47314095 |
| 48 | BRSK1 | 1.43629825 |
| 49 | BRAF | 1.43604684 |
| 50 | PINK1 | 1.40309202 |
| 51 | ATR | 1.40184331 |
| 52 | PTK6 | 1.35182901 |
| 53 | DAPK2 | 1.34527062 |
| 54 | MAP3K8 | 1.29378110 |
| 55 | CHEK2 | 1.27460930 |
| 56 | TGFBR2 | 1.24633524 |
| 57 | WNK4 | 1.24525275 |
| 58 | TBK1 | 1.22367460 |
| 59 | MST4 | 1.21132829 |
| 60 | CHEK1 | 1.20868945 |
| 61 | PLK3 | 1.18669352 |
| 62 | WNK1 | 1.18617926 |
| 63 | CDK19 | 1.17685854 |
| 64 | FRK | 1.16309435 |
| 65 | NEK9 | 1.14362552 |
| 66 | KDR | 1.13876734 |
| 67 | ABL2 | 1.11127622 |
| 68 | JAK2 | 1.11031130 |
| 69 | ATM | 1.08041879 |
| 70 | ICK | 1.06095522 |
| 71 | PASK | 1.04943314 |
| 72 | NME1 | 1.03898211 |
| 73 | TIE1 | 1.02258305 |
| 74 | PRKAA2 | 1.01550570 |
| 75 | JAK1 | 0.99723917 |
| 76 | MAPK15 | 0.98232018 |
| 77 | MET | 0.95815340 |
| 78 | FGFR2 | 0.94922234 |
| 79 | PLK2 | 0.92211382 |
| 80 | STK4 | 0.90223279 |
| 81 | CDK12 | 0.88519128 |
| 82 | TESK2 | 0.88499447 |
| 83 | TRPM7 | 0.87920605 |
| 84 | RPS6KB2 | 0.87887066 |
| 85 | DYRK1B | 0.87071752 |
| 86 | EPHB1 | 0.85717119 |
| 87 | CDK1 | 0.84435366 |
| 88 | ACVR1B | 0.83695015 |
| 89 | STK16 | 0.82968019 |
| 90 | CDK6 | 0.82477730 |
| 91 | STK3 | 0.81483184 |
| 92 | RET | 0.80040318 |
| 93 | PRKCZ | 0.79948823 |
| 94 | MKNK1 | 0.79165272 |
| 95 | ERBB2 | 0.79134463 |
| 96 | MAPK4 | 0.78747271 |
| 97 | IRAK3 | 0.78391792 |
| 98 | EPHA3 | 0.76960372 |
| 99 | SCYL2 | 0.74672154 |
| 100 | MAP3K7 | 0.73198209 |
| 101 | PRKACG | 0.72982729 |
| 102 | CDK2 | 0.72743285 |
| 103 | CSK | 0.71478910 |
| 104 | AURKB | 0.69950681 |
| 105 | MAP3K14 | 0.67208843 |
| 106 | MAP3K10 | 0.65981646 |
| 107 | MKNK2 | 0.65497025 |
| 108 | MAP3K13 | 0.65420447 |
| 109 | CSF1R | 0.64523873 |
| 110 | PRKAA1 | 0.62761945 |
| 111 | GRK1 | 0.57388921 |
| 112 | IKBKE | 0.57246972 |
| 113 | AURKA | 0.54231131 |
| 114 | CAMK2G | 0.53866186 |
| 115 | IRAK1 | 0.53642707 |
| 116 | CSNK1E | 0.52202830 |
| 117 | GSK3A | 0.51742907 |
| 118 | CAMK1D | 0.51533530 |
| 119 | YES1 | 0.51071108 |
| 120 | CSNK2A2 | 0.50573311 |
| 121 | PRKCG | 0.50307697 |
| 122 | CDK7 | 0.49964153 |
| 123 | ALK | 0.49175780 |
| 124 | CDK4 | 0.48239145 |
| 125 | SGK3 | 0.48189871 |
| 126 | TYRO3 | 0.47909730 |
| 127 | GRK6 | 0.47453752 |
| 128 | MAP2K6 | 0.47228772 |
| 129 | MARK3 | 0.46952327 |
| 130 | LATS2 | 0.46721058 |
| 131 | PAK1 | 0.46324292 |
| 132 | FGFR3 | 0.46151509 |
| 133 | SGK1 | 0.44781864 |
| 134 | PDK1 | 0.44233683 |
| 135 | MAPK12 | 0.44066812 |
| 136 | IGF1R | 0.43538314 |
| 137 | MTOR | 0.42933682 |
| 138 | BLK | 0.42384090 |
| 139 | MAP2K3 | 0.41442523 |
| 140 | MAPKAPK5 | 0.41103357 |
| 141 | MAP3K1 | 0.39348438 |
| 142 | OXSR1 | 0.38247394 |
| 143 | PRKDC | 0.38196175 |
| 144 | DYRK3 | 0.37969441 |
| 145 | PTK2B | 0.37827629 |
| 146 | CSNK2A1 | 0.37463316 |
| 147 | PRKCQ | 0.37345834 |
| 148 | RPS6KB1 | 0.35998370 |
| 149 | MAPK13 | 0.35426839 |
| 150 | BRD4 | 0.34683512 |
| 151 | PDPK1 | 0.34495726 |
| 152 | TNK2 | 0.33137238 |
| 153 | NEK6 | 0.32703341 |
| 154 | SGK2 | 0.32432313 |
| 155 | PRKCI | 0.32134955 |
| 156 | STK38 | 0.31588032 |
| 157 | ABL1 | 0.31453510 |
| 158 | CSNK1G1 | 0.30440402 |
| 159 | PTK2 | 0.29505046 |
| 160 | EGFR | 0.29488218 |
| 161 | MAP4K2 | 0.29286778 |
| 162 | RIPK1 | 0.29209123 |
| 163 | GSK3B | 0.28965478 |
| 164 | STK10 | 0.28691882 |
| 165 | MAPK14 | 0.27998085 |
| 166 | TGFBR1 | 0.26749383 |
| 167 | MAP2K1 | 0.26617041 |
| 168 | CDK11A | 0.25574272 |
| 169 | IRAK2 | 0.25370082 |
| 170 | MAP3K3 | 0.25221616 |
| 171 | PKN1 | 0.25139501 |
| 172 | MAPK7 | 0.24063878 |
| 173 | CAMK4 | 0.23488483 |
| 174 | MAP3K6 | 0.21249286 |
| 175 | PRKCA | 0.20813518 |
| 176 | NUAK1 | 0.20745485 |
| 177 | EIF2AK2 | 0.20070294 |
| 178 | BMX | 0.19602977 |
| 179 | PRKACB | 0.17200808 |
| 180 | CAMK1G | 0.16486964 |
| 181 | MAPK3 | 0.16464134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56691905 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.09756794 |
| 3 | Homologous recombination_Homo sapiens_hsa03440 | 3.92382604 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.85579592 |
| 5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.52865567 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33930487 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.27930708 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.11279013 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.97880457 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.92319471 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.90600401 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90285602 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73910617 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64610536 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64463255 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.63321752 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.61267216 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.58859260 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55447840 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49643293 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.44690895 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41875018 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 2.28733923 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20944937 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17046848 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 2.12057315 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10580979 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08965292 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 2.08452737 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 2.05391248 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.04102907 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99580541 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96592775 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95757528 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91523643 |
| 36 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.90611936 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.88901860 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86808630 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85391679 |
| 40 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.80900066 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78754361 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.78130859 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77346728 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.76442161 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67522216 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67216106 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65932997 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63805947 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 1.58351673 |
| 50 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.51248031 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.50381906 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49649049 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 1.47274942 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46108570 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45127867 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.43389891 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 1.42506595 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39762993 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39141560 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35173794 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.33168406 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29560046 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26995945 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23718223 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22785258 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20911248 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18248553 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15213173 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12552742 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09864820 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07540286 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03549849 |
| 73 | Purine metabolism_Homo sapiens_hsa00230 | 1.03040689 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99993272 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.97027582 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95374906 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94351727 |
| 78 | Protein export_Homo sapiens_hsa03060 | 0.93812970 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93173598 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90049297 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85815675 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83966407 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.83845479 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83510238 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83454493 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82446947 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79159272 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.79141511 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77617742 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77093527 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75686454 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71467117 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68391129 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65915408 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64009268 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63862648 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62660694 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59279371 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55303184 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54051948 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52520350 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52506126 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52286286 |
| 104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51792212 |
| 105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45270669 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.41502385 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38004575 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37944297 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36774638 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36522488 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32534091 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31729617 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30911680 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30636955 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30274309 |
| 116 | Phototransduction_Homo sapiens_hsa04744 | 0.29717634 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28008695 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23085248 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21565440 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20915950 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.19795753 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17880027 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17338551 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17126826 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16820085 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16399897 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15843714 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15459227 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.15285859 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14820654 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01123772 |
| 132 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.00985108 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2319994 |
| 134 | Malaria_Homo sapiens_hsa05144 | -0.2306287 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2079083 |
| 136 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2052252 |
| 137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1972299 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1853456 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1847960 |
| 140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1842274 |
| 141 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1777081 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | -0.1768748 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | -0.1673730 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1638380 |
| 145 | Legionellosis_Homo sapiens_hsa05134 | -0.1526500 |
| 146 | Pertussis_Homo sapiens_hsa05133 | -0.1475507 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1461706 |
| 148 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1359819 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1086822 |
| 150 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1012236 |
| 151 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0880388 |
| 152 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0256800 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0017714 |

